Haider; Stefan
Patent Applications and Registrations
Patent applications and USPTO patent grants for Haider; Stefan.The latest application filed is for "nucleophilic catalysts for oxime linkage".
- Haider; Stefan - Prinzersdorf AT
- Haider; Stefan - Prinzerdorf N/A AT
| Patent | Date |
|---|---|
| Blood coagulation protein conjugates Grant 11,040,109 - Siekmann , et al. June 22, 2 | 2021-06-22 |
| Nucleophilic Catalysts For Oxime Linkage App 20210163527 - Haider; Stefan ; et al. | 2021-06-03 |
| Glycopolysialylation of non-blood coagulation proteins Grant 10,772,968 - Jain , et al. Sept | 2020-09-15 |
| Nucleophilic Catalysts For Oxime Linkage App 20200230252 - Siekmann; Juergen ; et al. | 2020-07-23 |
| Nucleophilic catalysts for oxime linkage Grant 10,576,160 - Siekmann , et al. | 2020-03-03 |
| Nucleophilic Catalysts For Oxime Linkage App 20200017543 - Haider; Stefan ; et al. | 2020-01-16 |
| Blood Coagulation Protein Conjugates App 20190314516 - Siekmann; Juergen ; et al. | 2019-10-17 |
| Nucleophilic catalysts for oxime linkage Grant 10,414,793 - Haider , et al. Sept | 2019-09-17 |
| Blood coagulation protein conjugates Grant 10,350,301 - Siekmann , et al. July 16, 2 | 2019-07-16 |
| Glycopolysialylation Of Non-blood Coagulation Proteins App 20180200380 - Jain; Sanjay ; et al. | 2018-07-19 |
| Nucleophilic Catalysts For Oxime Linkage App 20170368193 - Siekmann; Juergen ; et al. | 2017-12-28 |
| Glycopolysialylation of non-blood coagulation proteins Grant 9,795,683 - Jain , et al. October 24, 2 | 2017-10-24 |
| Nucleophilic Catalysts For Oxime Linkage App 20170240590 - Haider; Stefan ; et al. | 2017-08-24 |
| Nucleophilic catalysts for oxime linkage Grant 9,731,024 - Siekmann , et al. August 15, 2 | 2017-08-15 |
| Blood Coagulation Protein Conjugates App 20160361430 - Siekmann; Juergen ; et al. | 2016-12-15 |
| Nucleophilic catalysts for oxime linkage Grant 9,492,555 - Haider , et al. November 15, 2 | 2016-11-15 |
| Blood Coagulation Protein Conjugates App 20160120994 - Siekmann; Juergen ; et al. | 2016-05-05 |
| Nucleophilic Catalysts For Oxime Linkage App 20150024455 - Siekmann; Juergen ; et al. | 2015-01-22 |
| Nucleophilic catalysts for oxime linkage Grant 8,809,501 - Siekmann , et al. August 19, 2 | 2014-08-19 |
| Nucleophilic Catalysts For Oxime Linkage App 20140121351 - Haider; Stefan ; et al. | 2014-05-01 |
| Blood Coagulation Protein Conjugates App 20140107320 - Haider; Stefan ; et al. | 2014-04-17 |
| Nucleophilic catalysts for oxime linkage Grant 8,642,737 - Siekmann , et al. February 4, 2 | 2014-02-04 |
| Blood coagulation protein conjugates Grant 8,637,640 - Siekmann , et al. January 28, 2 | 2014-01-28 |
| Nucleophilic Catalysts For Oxime Linkage And Use Of Nmr Analyses Of The Same App 20130310546 - Ray; G. Joseph ; et al. | 2013-11-21 |
| Nucleophilic Catalysts For Oxime Linkage App 20130011900 - Siekmann; Juergen ; et al. | 2013-01-10 |
| Nucleophilic Catalysts For Oxime Linkage App 20120035344 - Siekmann; Juergen ; et al. | 2012-02-09 |
| Glycopolysialylation Of Non-blood Coagulation Proteins App 20110027350 - Jain; Sanjay ; et al. | 2011-02-03 |
| Blood Coagulation Protein Conjugates App 20110028693 - SIEKMANN; JUERGEN ; et al. | 2011-02-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 